[go: up one dir, main page]

WO2009072581A1 - ラクタム化合物又はその塩及びｐｐａｒ活性化剤 - Google Patents

ラクタム化合物又はその塩及びｐｐａｒ活性化剤 Download PDF

Info

Publication number
WO2009072581A1
WO2009072581A1 PCT/JP2008/072094 JP2008072094W WO2009072581A1 WO 2009072581 A1 WO2009072581 A1 WO 2009072581A1 JP 2008072094 W JP2008072094 W JP 2008072094W WO 2009072581 A1 WO2009072581 A1 WO 2009072581A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
atom
salt
integer
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/072094
Other languages
English (en)
French (fr)
Inventor
Tomoji Aotsuka
Hashime Kanazawa
Kentarou Kumazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Aska Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aska Pharmaceutical Co Ltd filed Critical Aska Pharmaceutical Co Ltd
Priority to JP2009544722A priority Critical patent/JP5632612B2/ja
Publication of WO2009072581A1 publication Critical patent/WO2009072581A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyamides (AREA)

Abstract

　ＰＰＡＲ活性化剤として有用なラクタム骨格を有する化合物又はその塩を提供する。 　式（１）で表されるラクタム化合物又はその塩。 ［式中、Ｒ１はハロゲン、炭化水素基、カルボキシル基などを示し、Ｚ１はアレーン環又はヘテロ環、Ｚ３は脂環族又は芳香族炭化水素環を示し、Ｚ２は、５～６員窒素原子含有環であり、Ｘ１は、Ｃ、Ｏ、Ｓ又はＮ原子、基－Ｎ－Ｃ（＝Ｏ）－又は基－Ｃ（＝Ｏ）－Ｎ－を示し、Ｒ２は、水素原子又は置換基を有していてもよいアルキル基を示し、Ｒ３及びＲ４はそれぞれ単結合又は二価の脂肪族炭化水素基を示し、少なくとも一方が脂肪族炭化水素基であり、Ｘ２及びＸ３は、単結合、Ｏ又はＳ原子、イミノ基などを示し、Ａ１は、単結合又は置換基を有していてもよいフェニレン基を示し、Ｙ１は水素原子、ハロゲン原子、カルボキシル基などを示し、ａは０～５、ｂは０～２及びｃは１～３の整数を示す］  
PCT/JP2008/072094 2007-12-05 2008-12-04 ラクタム化合物又はその塩及びｐｐａｒ活性化剤 Ceased WO2009072581A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009544722A JP5632612B2 (ja) 2007-12-05 2008-12-04 ラクタム化合物又はその塩及びｐｐａｒ活性化剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007315021 2007-12-05
JP2007-315021 2007-12-05

Publications (1)

Publication Number Publication Date
WO2009072581A1 true WO2009072581A1 (ja) 2009-06-11

Family

ID=40717759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/072094 Ceased WO2009072581A1 (ja) 2007-12-05 2008-12-04 ラクタム化合物又はその塩及びｐｐａｒ活性化剤

Country Status (2)

Country Link
JP (1) JP5632612B2 (ja)
WO (1) WO2009072581A1 (ja)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010280592A (ja) * 2009-06-03 2010-12-16 Aska Pharmaceutical Co Ltd ラクタム化合物又はその塩及びｐｐａｒ活性化剤
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011161030A1 (de) 2010-06-21 2011-12-29 Sanofi Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren
WO2012004269A1 (de) 2010-07-05 2012-01-12 Sanofi ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012004270A1 (de) 2010-07-05 2012-01-12 Sanofi Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012010413A1 (de) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JP2012512893A (ja) * 2008-12-18 2012-06-07 メタボレックス， インコーポレイテッド Ｇｐｒ１２０受容体作動薬およびその使用
WO2012081570A1 (ja) * 2010-12-14 2012-06-21 あすか製薬株式会社 ラクタム化合物又はその塩及びｐｐａｒ活性化剤
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2013217695A (ja) * 2012-04-05 2013-10-24 Shimadzu Corp 質量分析用マトリックスの添加剤
WO2016114668A1 (en) 2015-01-16 2016-07-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method to prepare phenolics from biomass
EP3184505A1 (en) 2015-12-22 2017-06-28 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Method for preparing phenolics using a catalyst
WO2018172852A1 (en) * 2017-03-21 2018-09-27 Arbutus Biopharma Corporation Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
KR101902045B1 (ko) 2011-07-05 2018-09-27 바스프 에스이 락탐, 활성화제 및 촉매를 함유하는 고체 입자, 상기 고체 입자의 제조 방법, 및 상기 고체 입자의 용도
CN110526856A (zh) * 2019-09-12 2019-12-03 天津瑞岭化工有限公司 Dwp205190的合成方法
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
US10752626B2 (en) * 2016-07-14 2020-08-25 Shanghai Meton Pharmaceutical Co., Ltd Iso-citrate dehydrogenase (IDH) inhibitor
US11071793B2 (en) * 2014-08-29 2021-07-27 Chdi Foundation, Inc. Probes for imaging huntingtin protein
US11236103B2 (en) 2018-07-27 2022-02-01 Biotheryx, Inc. Bifunctional compounds
CN114773162A (zh) * 2022-03-27 2022-07-22 江苏壹药新材料有限公司 一种4-(3-羟基丙烯基)-2-三氟甲基苯酚的合成方法
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
JP2024102266A (ja) * 2017-10-25 2024-07-30 東京応化工業株式会社 メルカプト化合物
WO2024229121A1 (en) * 2023-05-02 2024-11-07 Genesis Therapeutics, Inc. Compounds for treating cancer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503418A (ja) * 1995-03-29 1999-03-26 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼ阻害剤
JP2000514061A (ja) * 1996-06-28 2000-10-24 メルク エンド カンパニー インコーポレーテッド フィブリノーゲン受容体拮抗物質
JP2006516254A (ja) * 2003-01-06 2006-06-29 イーライ・リリー・アンド・カンパニー Ｐｐａｒモジュレータとしての縮合ヘテロ環誘導体
JP2007514659A (ja) * 2003-11-25 2007-06-07 イーライ リリー アンド カンパニー ペルオキシソーム増殖因子活性化受容体の修飾因子

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980074060A (ko) * 1997-03-21 1998-11-05 김윤배 신규한 치환된 3,4-디알콕시페닐 유도체
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US7320992B2 (en) * 2003-08-25 2008-01-22 Amgen Inc. Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
CA2612008A1 (en) * 2005-06-29 2007-01-04 Palau Pharma, S.A. Bicyclic derivatives as p38 kinase inhibitors
US8110681B2 (en) * 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503418A (ja) * 1995-03-29 1999-03-26 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼ阻害剤
JP2000514061A (ja) * 1996-06-28 2000-10-24 メルク エンド カンパニー インコーポレーテッド フィブリノーゲン受容体拮抗物質
JP2006516254A (ja) * 2003-01-06 2006-06-29 イーライ・リリー・アンド・カンパニー Ｐｐａｒモジュレータとしての縮合ヘテロ環誘導体
JP2007514659A (ja) * 2003-11-25 2007-06-07 イーライ リリー アンド カンパニー ペルオキシソーム増殖因子活性化受容体の修飾因子

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HALL,I.H. ET AL.: "Effects of N-substituted phthalimide, saccharin, succinimide, and indandione derivatives on the type I and II isoforms of human Tmolt4 T cell IMP dehydrogenase, Research Communications", PHARMACOLOGY AND TOXICOLOGY, vol. 6, no. 1 & 2, 2001, pages 19 - 33 *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012512893A (ja) * 2008-12-18 2012-06-07 メタボレックス， インコーポレイテッド Ｇｐｒ１２０受容体作動薬およびその使用
JP2010280592A (ja) * 2009-06-03 2010-12-16 Aska Pharmaceutical Co Ltd ラクタム化合物又はその塩及びｐｐａｒ活性化剤
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011161030A1 (de) 2010-06-21 2011-12-29 Sanofi Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren
WO2012004269A1 (de) 2010-07-05 2012-01-12 Sanofi ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012004270A1 (de) 2010-07-05 2012-01-12 Sanofi Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012010413A1 (de) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPWO2012081570A1 (ja) * 2010-12-14 2014-05-22 あすか製薬株式会社 ラクタム化合物又はその塩及びｐｐａｒ活性化剤
WO2012081570A1 (ja) * 2010-12-14 2012-06-21 あすか製薬株式会社 ラクタム化合物又はその塩及びｐｐａｒ活性化剤
KR101902045B1 (ko) 2011-07-05 2018-09-27 바스프 에스이 락탐, 활성화제 및 촉매를 함유하는 고체 입자, 상기 고체 입자의 제조 방법, 및 상기 고체 입자의 용도
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2013217695A (ja) * 2012-04-05 2013-10-24 Shimadzu Corp 質量分析用マトリックスの添加剤
US12036291B2 (en) 2014-08-29 2024-07-16 Chdi Foundation, Inc. Probes for imaging huntingtin protein
US11071793B2 (en) * 2014-08-29 2021-07-27 Chdi Foundation, Inc. Probes for imaging huntingtin protein
WO2016114668A1 (en) 2015-01-16 2016-07-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method to prepare phenolics from biomass
EP3184505A1 (en) 2015-12-22 2017-06-28 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Method for preparing phenolics using a catalyst
WO2017111595A1 (en) 2015-12-22 2017-06-29 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for preparing phenolics using a catalyst
US10752626B2 (en) * 2016-07-14 2020-08-25 Shanghai Meton Pharmaceutical Co., Ltd Iso-citrate dehydrogenase (IDH) inhibitor
WO2018172852A1 (en) * 2017-03-21 2018-09-27 Arbutus Biopharma Corporation Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
US11098010B2 (en) 2017-03-21 2021-08-24 Arbutus Biopharma Corporation Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
US10927104B2 (en) 2017-08-25 2021-02-23 Biotheryx, Inc. Ether compounds and uses thereof
JP2024102266A (ja) * 2017-10-25 2024-07-30 東京応化工業株式会社 メルカプト化合物
US11236103B2 (en) 2018-07-27 2022-02-01 Biotheryx, Inc. Bifunctional compounds
CN110526856B (zh) * 2019-09-12 2023-04-07 天津瑞岭化工有限公司 Dwp205190的合成方法
CN110526856A (zh) * 2019-09-12 2019-12-03 天津瑞岭化工有限公司 Dwp205190的合成方法
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
CN114773162A (zh) * 2022-03-27 2022-07-22 江苏壹药新材料有限公司 一种4-(3-羟基丙烯基)-2-三氟甲基苯酚的合成方法
WO2024229121A1 (en) * 2023-05-02 2024-11-07 Genesis Therapeutics, Inc. Compounds for treating cancer

Also Published As

Publication number Publication date
JPWO2009072581A1 (ja) 2011-04-28
JP5632612B2 (ja) 2014-11-26

Similar Documents

Publication Publication Date Title
WO2009072581A1 (ja) ラクタム化合物又はその塩及びｐｐａｒ活性化剤
WO2009016841A1 (ja) オキソピラジン誘導体及び除草剤
MX2008014908A (es) Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
MY153910A (en) BICYCLIC y-AMINO ACID DERIVATIVE
WO2008108380A3 (en) Pyrrole compounds
WO2009020140A1 (ja) アダマンチルウレア誘導体
MX2014000452A (es) Derivados de azabencimiazol que tiene actividad activadora de la proteina cinasa activada monofosfato de denosina (ampk).
JO2791B1 (en) Acid secretion inhibitor
EA201070994A1 (ru) Конденсированное гетероциклическое производное и его применение
WO2008114817A1 (ja) 新規なアデニン化合物
WO2008078686A1 (ja) オキシムエステル化合物及び該化合物を含有する光重合開始剤
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
MY153720A (en) Oxazole compound and pharmaceutical composition
UA105185C2 (uk) Піроли
WO2008126890A1 (ja) ヒドラジド化合物およびそれを含有する有害節足動物防除剤
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
WO2008096829A1 (ja) ３環系化合物
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
MX2009007954A (es) Derivado de heterocicliden-n-(aril) acetamida.
MY169179A (en) Novel piperidine compound or salt thereof
WO2008136444A1 (ja) 縮合複素環誘導体
TW200744659A (en) Preparation for preventing and ameliorating wrinkle

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08858226

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009544722

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08858226

Country of ref document: EP

Kind code of ref document: A1